Open AccessAbstract CT148: Clinical results of the multiparameter phase 1 trial EVESOR meant to optimize the doses and dosing schedules of the combination EVErolimus and SORafenib in solid tumors
Author(s) -
Benoît You,
Michel Tod,
Léa Payen,
Jonathan Lopez,
Jérôme Guitton,
Pascal Rousset,
Juliette Fontaine,
Julien Péron,
Denis Maillet,
Sophie Tartas,
Nathalie Bonnin,
Véronique TrilletLenoir,
Olivier Colomban,
Diane Augu-Denechere,
Gilles Freyer,
Alicja Puszkiel
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct148
Subject(s) - dosing , medicine , everolimus , sorafenib , pharmacokinetics , pharmacodynamics , pharmacology , clinical trial , oncology , hepatocellular carcinoma